中文

华绿生物 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-22
ItemAmountY/Y
Revenue¥0.41B+53.1%
Gross profit¥0.13B
Operating income¥0.12B
Net income¥0.12B+5972.0%
Gross margin32.1%Net margin 28.8%
Revenue Q/Q-2.4%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.28B67.9%
R&D¥0.00B0.9%
SG&A¥0.02B4.1%
Tax & other¥-0.00B-0.0%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

博亚精工万辰集团立高食品商络电子达瑞电子深圳瑞捷东箭科技华利集团祥源新材中红医疗苏文电能尤安设计

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies